116 related articles for article (PubMed ID: 30911995)
41. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
[TBL] [Abstract][Full Text] [Related]
42. RASSF10 regulates bone invasion of growth hormone-secreting adenomas via exosomes.
Wang T; Liu H; Ji Z; Cheng Y; Du Y; Liu H; Liao J; Peng H
Biochem Biophys Res Commun; 2020 Jun; 527(3):603-610. PubMed ID: 32423821
[TBL] [Abstract][Full Text] [Related]
43. β-Catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression.
Zhao C; Zhang M; Liu W; Wang C; Zhang Q; Li W
Int J Oncol; 2015 Apr; 46(4):1643-50. PubMed ID: 25646597
[TBL] [Abstract][Full Text] [Related]
44. Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival.
Xu M; Shorts-Cary L; Knox AJ; Kleinsmidt-DeMasters B; Lillehei K; Wierman ME
Endocrinology; 2009 May; 150(5):2064-71. PubMed ID: 19116338
[TBL] [Abstract][Full Text] [Related]
45. The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours.
Øystese KAB; Berg JP; Normann KR; Zucknick M; Casar-Borota O; Bollerslev J
Endocrine; 2018 Nov; 62(2):351-360. PubMed ID: 30051197
[TBL] [Abstract][Full Text] [Related]
46. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
47. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
48. MAMLD1 (CXorf6) is a New Gene for Hypospadias.
Ogata T; Fukami M; Wada Y
Clin Pediatr Endocrinol; 2008; 17(4):87-93. PubMed ID: 24790369
[TBL] [Abstract][Full Text] [Related]
49. Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma.
Zhang Y; Liu YT; Tang H; Xie WQ; Yao H; Gu WT; Zheng YZ; Shang HB; Wang Y; Wei YX; Wu ZR; Wu ZB
J Clin Endocrinol Metab; 2019 Dec; 104(12):6345-6356. PubMed ID: 31369093
[TBL] [Abstract][Full Text] [Related]
50. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
51. Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas.
Kumar TR; Graham KE; Asa SL; Low MJ
Endocrinology; 1998 Jul; 139(7):3342-51. PubMed ID: 9645710
[TBL] [Abstract][Full Text] [Related]
52. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
[TBL] [Abstract][Full Text] [Related]
54. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
55. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression.
Zhang Y; Tan Y; Wang H; Xu M; Xu L
Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907
[TBL] [Abstract][Full Text] [Related]
56. [Gonadotroph pituitary adenomas].
Chanson P
Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
[TBL] [Abstract][Full Text] [Related]
57. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
Johnson MD; Fan X; Bourne P; Walters D
J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
[TBL] [Abstract][Full Text] [Related]
58. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.
Ezzat S; Yu S; Asa SL
Am J Pathol; 2003 Sep; 163(3):1177-84. PubMed ID: 12937159
[TBL] [Abstract][Full Text] [Related]
59. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
[TBL] [Abstract][Full Text] [Related]
60. Molecular characterisation and functional interrogation of a local natriuretic peptide system in rodent pituitaries, alphaT3-1 and LbetaT2 gonadotroph cells.
Thompson IR; Chand AN; Jonas KC; Burrin JM; Steinhelper ME; Wheeler-Jones CP; McArdle CA; Fowkes RC
J Endocrinol; 2009 Nov; 203(2):215-29. PubMed ID: 19666697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
